Our Company
Key Facts
Leadership
Governance
History
Compliance & Ethics
Diversity & Inclusion
Our Websites
Achievements
Business Information
R&D
R&D Strategy
In the Pipeline
Disease Areas of Focus
Our R&D
Our Science
R&D Highlights
Major R&D Facilities
Clinical Trials
Products
Patient Assistance Programs
Prescribing Information
R&D
Clinical Trials
Counterfeit Drugs
News
Press Releases
Publications
Media Library
Key Facts
Leadership
Financial Reporting
Features
Achievements
Media Contacts
Subscribe to e-mail alerts
Investors
Key Facts
Stock Information
SEC Filings
Financial Reporting
Events & Presentations
Shareholder Services
Investor Contacts
Partnering
Why Partner With Us?
Areas of Interest
Our Process
Our Partners
Partnering News
Partnering Contact
Responsibility
Bristol-Myers Squibb Foundation
Sustainability
Patient Assistance Programs
Building Our Communities
Grants & Giving
Position on Key Issues
Clinical Trials
Combating Counterfeit Drugs
Achievements
Careers
Job Opportunities
Our Culture
Diversity & Inclusion
Developing Our People
University Recruitment
Achievements
Benefits
Manage My Profile
Apply Now
SITE INDEX
|
CONTACT US
|
TERMS
|
PRIVACY
Health Care Professionals
Access
medical information and resources
Clinical Trials
Bristol-Myers Squibb-sponsored
clinical trials
Need Help Paying for Your Bristol-Myers Squibb Medicines?
Learn about our
assistance programs
.
August 20, 2009
Derivative Action Settlement Notice
Our Environmental Stewardship
Bristol-Myers Squibb recognizes World Diabetes Day.
Read
how biopharmaceutical companies are developing new and more effective treatments.
LATEST NEWS
November 20, 2009
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
November 16, 2009
Bristol-Myers Squibb Announces Split-Off of Mead Johnson
November 10, 2009
Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
November 10, 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic